Quick Answer
Heartflow, Inc. reported R&D Expense of $64.92 million for fiscal year 2025.
Heartflow, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $64.92M | +49.2% |
| 2024 | $43.52M | +21.4% |
| 2023 | $35.85M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $17.30M | +45.8% | +15.1% |
| June 30, 2025 | $15.03M | +51.3% | +26.7% |
| September 30, 2024 | $11.86M | — | +19.4% |
| June 30, 2024 | $9.93M | — | — |
- Heartflow, Inc. showed an increase of +49.2% in R&D Expense compared to the prior fiscal year.
- Over the 2023–2025 period, Heartflow, Inc.’s r&d expense has grown by 81.1% (from $35.85 million to $64.92 million).
- The most recent figure is from Heartflow, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 18, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: